S.-H.I. Ou

Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs

S.-H.I. Ou, F Wu, David Harrich et al. · Journal of Virology · 1995 · 760 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

Tony Mok, D. Ross Camidge, Shirish M. Gadgeel et al. · Annals of Oncology · 2020 · 686 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

Alexander Drilon, G. Li, Snjezana Doğan et al. · Annals of Oncology · 2016 · 302 citations · Full text

Medicine, Oncology, Pharmacology +17

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Stephen V. Liu, Caroline E. McCoach, Viola W. Zhu et al. · Annals of Oncology · 2020 · 227 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

S.-H.I. Ou, Pasi A. Jänne, Cynthia Huang Bartlett et al. · Annals of Oncology · 2014 · 220 citations · Full text

Medicine, Oncology, Pharmacology +14